"HTN:RDN" The Definitive 4-Part Documentary Series on Hypertension & Renal Denervation (Trailer)

  • 3,600 views
  • 05 Mar 2020
Like Comment

Share

Save

Hypertension Hypertension - Treatment Renal Denervation (RDN)

WONDR

Follow

WONDR is a medical publisher run by physicians for physicians bringing together medical educational resources from leading courses and conferences from all around the world.

David Kandzari

Dr. Kandzari is Director of Interventional Cardiology, Piedmont Heart Institute and Chief Scientific Officer, Piedmont Healthcare. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine.

Link to profile Follow

Michael Böhm

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. He has been the principal investigator in several international multicenter studies.

Link to profile Follow

Joachim Weil

Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is interventional therapy of coronary artery disease and arterial hypertension including renal denervation as well chronic heart failure

Link to profile Follow

Felix Mahfoud

Dr Felix Mahfoud is associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital. He is involved in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.

Link to profile Follow

Peter Sever

Prof. Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London. His research is in the pathophysiology of vascular disease, the evaluation of anti-hypertensive drug therapy and multiple risk factor intervention in hypertensive populations.

Link to profile Follow

Costas Tsioufis

Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director of the Hypertension Unit, 1st Cardiology Clinic, Hippokration Hospital, Athens, Greece. Interventional Cardiologist and Hypertension Specialist.

Link to profile Follow

Related Videos

open video

CRT

Ongoing Efforts Identifying Predictors of Response to Renal Denervation for...

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Post-Results Panel Discussion PART 2

open video

WONDR

Patient preference and bringing it all together

open video

Wondr Studios

My view on the future of RDN - Markus Schlaich

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

CRT

Update on the SPYRAL Renal Artery Denervation Trials